Table 3.
Genotypes of Staphylococcus aureus isolates from HIV patients and healthy controls, in Gabon in 2013.
| CC | ST | Isolates from HIV-positive participants (n = 56) |
Isolates from healthy controls (n = 69) |
OR (95% CI)a | Pa | ||
|---|---|---|---|---|---|---|---|
| S. aureus spa types (n) | Total | S. aureus spa types (n) | Total | ||||
| CC5 | ST1 | t127 (1) | 64.9% | t127 (3), t4448 (1) | 72.1% | 1.32 (0.58–3.01) | 0.5 |
| ST5 | t5987 (1) | t319 (3), t1400 (2), t5987 (4) | |||||
| ST6 | t701 (1), t1476 (3) | t304 (1), t701 (1), t1476 (4) | |||||
| ST8 | t121 (1), t064 (1), t12858 (2) | t451 (1), t1476 (2) | |||||
| ST9 | t1045 (1) | t1045 (1) | |||||
| ST15 | t084 (15), t094 (1), t491 (2), t803 (1) | t084 (12), t085 (1), t279 (2), t12523 (1) | |||||
| ST72 | t148 (3) | t148 (3), t2464 (1), t11108 (1) | |||||
| ST188 | t189 (1) | t189 (1) | |||||
| ST573 | t1579 (1) | – | |||||
| ST2708 | t311 (1) | t311 (3) | |||||
| ST2736 | – | t254 (1) | |||||
| ST2765 | t11644 (1) | – | |||||
| CC45 | ST45 | t939 (2) | 7.0% | t12857 (1) | 4.4% | 0.6 (0.08-3.74) | 0.7 |
| ST508 | t015 (1), t073 (1) | t12525 (1) | |||||
| ST2498 | – | t827 (1) | |||||
| CC101 | ST101 | t056 (1) | 1.8% | t056 (4), t3165 (1), t4679 (2) | 10.3% | 6.32 (0.76-289.54) | 0.07 |
| CC152 | ST152 | t355 (10) | 17.5% | t355 (8) | 11.8% | 0.62 (0.2-1.9) | 0.3 |
| Other | ST7 | t091 (1) | 8.8% | – | 1.5% | 0.31 (0.03-2.01) | 0.2 |
| ST88 | t12856 (1) | t2723 (1) | |||||
| ST121 | t645 (1) | – | |||||
| ST2349 | t026 (1) | – | |||||
| ST1223 | – | NT (1) | |||||
PVL, positive spa types in bold. aComparison of the proportion of clonal complexes (CC).